Search
Search Results
##search.searchResults.foundPlural##
-
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1764PDF: 1064HTML: 1896Untitled: 246Untitled: 223 -
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7165PDF: 3804HTML: 845 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4606Suppl. Files: 1255PDF: 1158Html: 312 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3951PDF: 1579HTML: 356 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5515PDF: 1416HTML: 2882Cover letter: 249 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2654PDF: 1796HTML: 699 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4663PDF: 1813HTML: 1323 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2391PDF: 1001HTML: 2378 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1895PDF: 941HTML: 1542 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2585PDF: 957HTML: 2583 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2712PDF: 940HTML: 17608Fig1 Caligaris: 234Fig.2 Caliga: 274 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2419PDF: 2153HTML: 238 -
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2410PDF: 1892HTML: 1011 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1199PDF: 1237Suppl. Files: 601HTML: 105 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3312PDF: 1200HTML: 1694Untitled: 222Untitled: 226Untitled: 213 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2656PDF: 903HTML: 9070Efremov 1: 275Efremov 2: 245 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3913PDF: 1712HTML: 105 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3239PDF: 955HTML: 7317Kost Fig1: 232Kost Fig 2: 219Kost Fig3: 233Kost Fig 4: 244Kost Fig5: 239Kost fig 6: 228 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3054PDF: 1174HTML: 135 -
How I treat acute and persistent sickle cell pain
2132PDF: 1188HTML: 793 -
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2969PDF: 1224HTML: 11431 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3916PDF: 1695HTML: 877Figures . Eliassian: 294 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3775PDF: 2635HTML: 1675 -
IMMUNOLOGY OF TUBERCULOSIS
5889PDF: 2280HTML: 7370Untitled: 248 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3415PDF: 1565HTML: 5973Fig1-Ag-Pil: 285Ag-Pil Fig.2: 285 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3929PDF: 1670HTML: 8254Randi Fig: 230 -
SICKLE CELL ANAEMIA AND MALARIA
11917PDF: 7353HTML: 24086Figures Malaria and SCK: 275 -
-
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2707PDF: 874HTML: 5389 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2322PDF: 1051HTML: 1992 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2453PDF: 1391HTML: 17221Bassan Fig.1: 183Bassan Fig.2: 287Bassan Fig.4: 173Fig.3: 269







